Resverlogix Corp. (TSE:RVX – Get Free Report)’s stock price passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.05 and traded as low as C$0.05. Resverlogix shares last traded at C$0.05, with a volume of 3,000 shares trading hands.
Resverlogix Price Performance
The company has a market capitalization of C$8.91 million, a price-to-earnings ratio of -2.23 and a beta of 0.71. The company has a debt-to-equity ratio of -10.95, a quick ratio of 0.04 and a current ratio of 0.13. The business has a 50 day moving average price of C$0.05 and a 200-day moving average price of C$0.06.
About Resverlogix
Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.
Featured Stories
- Five stocks we like better than Resverlogix
- How to Plot Fibonacci Price Inflection Levels
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- DuPont’s Electronics Spinoff: The Start of Something Big
- Canada Bond Market Holiday: How to Invest and Trade
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Resverlogix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resverlogix and related companies with MarketBeat.com's FREE daily email newsletter.
